- Home
- JGH vs NRC Comparison
JGH vs NRC Comparison
Compare JGH & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JGH
- NRC
- Stock Information
- Founded
- JGH 2014
- NRC 1981
- Country
- JGH United States
- NRC United States
- Employees
- JGH N/A
- NRC N/A
- Industry
- JGH Investment Managers
- NRC Biotechnology: Commercial Physical & Biological Resarch
- Sector
- JGH Finance
- NRC Health Care
- Exchange
- JGH Nasdaq
- NRC Nasdaq
- Market Cap
- JGH 306.4M
- NRC 310.8M
- IPO Year
- JGH N/A
- NRC N/A
- Fundamental
- Price
- JGH $13.40
- NRC $15.37
- Analyst Decision
- JGH
- NRC
- Analyst Count
- JGH 0
- NRC 0
- Target Price
- JGH N/A
- NRC N/A
- AVG Volume (30 Days)
- JGH 73.9K
- NRC 120.0K
- Earning Date
- JGH 01-01-0001
- NRC 07-28-2025
- Dividend Yield
- JGH 9.85%
- NRC 3.13%
- EPS Growth
- JGH N/A
- NRC N/A
- EPS
- JGH N/A
- NRC 0.77
- Revenue
- JGH N/A
- NRC $140,314,000.00
- Revenue This Year
- JGH N/A
- NRC N/A
- Revenue Next Year
- JGH N/A
- NRC N/A
- P/E Ratio
- JGH N/A
- NRC $18.84
- Revenue Growth
- JGH N/A
- NRC N/A
- 52 Week Low
- JGH $10.36
- NRC $9.76
- 52 Week High
- JGH $12.85
- NRC $22.99
- Technical
- Relative Strength Index (RSI)
- JGH 60.46
- NRC 53.66
- Support Level
- JGH $13.34
- NRC $14.45
- Resistance Level
- JGH $13.60
- NRC $16.21
- Average True Range (ATR)
- JGH 0.07
- NRC 0.64
- MACD
- JGH -0.01
- NRC 0.12
- Stochastic Oscillator
- JGH 50.62
- NRC 66.47
About JGH Nuveen Global High Income Fund of Beneficial Interest
Nuveen Global High Income Fund operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of current income. Its securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.